Véronique Dartois | Scholar Profiles and Rankings

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations (journal article) Dartois, Véronique \| Bonfield, Tracey L. \| Boyce, Jim P. \| Daley, Charles L. \| Dick, Thomas \| Gonzalez-Juarrero, Mercedes \| Gupta, Shashank \| Kramnik, Igor \| Lamichhane, Gyanu \| Laughon, Barbara E. \| ... \| Jackson, Mary Tuberculosis, volume 147 (2024). 10.1016/j.tube.2024.102503 Cited by (1) \| Cite \| Source
Rifampicin has no role in treatment of Mycobacterium avium complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpoint (journal article) van Ingen, Jakko \| Hoefsloot, Wouter \| Dartois, Véronique \| Dick, Thomas European Respiratory Journal, volume 63, issue 5, pages 2302210- (2024). 10.1183/13993003.02210-2023 Cited by (2) \| Cite \| Source
A pairwise approach to revitalize β-lactams for the treatment of TB (journal article) Negatu, Dereje A. \| Aragaw, Wassihun Wedajo \| Dartois, Véronique \| Dick, Thomas Antimicrobial Agents and Chemotherapy (2024). 10.1128/aac.00034-24 Cite \| Source
Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease (journal article) Dartois, Véronique \| Dick, Thomas Nature Reviews Drug Discovery, volume 23, issue 5, pages 381-403 (2024). 10.1038/s41573-024-00897-5 Cited by (4) \| Cite \| Source
Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits (journal article) Datta, Meenal \| Via, Laura E. \| Dartois, Véronique \| Weiner, Danielle M. \| Zimmerman, Matthew \| Kaya, Firat \| Walker, April M. \| Fleegle, Joel D. \| Raplee, Isaac D. \| McNinch, Colton \| ... \| Jain, Rakesh K. Proceedings of the National Academy of Sciences, volume 121, issue 14 (2024). 10.1073/pnas.2321336121 Cite \| Source
Mathematical model of oxygen, nutrient, and drug transport in tuberculosis granulomas (journal article) Datta, Meenal \| Kennedy, McCarthy \| Siri, Saeed \| Via, Laura E. \| Baish, James W. \| Xu, Lei \| Dartois, Véronique \| Barry, Clifton E. \| Jain, Rakesh K. PLOS Computational Biology, volume 20, issue 2, pages e1011847- (2024). 10.1371/journal.pcbi.1011847 Cited by (1) \| Cite \| Source
Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease (journal article) Negatu, Dereje A \| Shin, Sung Jae \| Kim, Su-Young \| Jhun, Byung Woo \| Dartois, Véronique \| Dick, Thomas The Journal of Infectious Diseases (2023). 10.1093/infdis/jiad591 Cited by (1) \| Cite \| Source
A preclinical model of TB meningitis to determine drug penetration and activity at the sites of disease (journal article) Lanni, Faye \| Antilus Sainte, Rosleine \| Hansen,, Mark \| Parigi, Paul \| Kaya, Firat \| LoMauro, Katherine \| Siow, Bernard \| Wilkinson, Robert J. \| Wasserman, Sean \| Podell, Brendan K. \| ... \| Dartois, Véronique Antimicrobial Agents and Chemotherapy, volume 67, issue 12 (2023). 10.1128/aac.00671-23 Cited by (1) \| Cite \| Source
Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model (journal article) Ramey, Michelle E. \| Kaya, Firat \| Bauman, Allison A. \| Massoudi, Lisa M. \| Sarathy, Jansy P. \| Zimmerman, Matthew D. \| Scott, Dashick W. L. \| Job, Alyx M. \| Miller-Dawson, Jake A. \| Podell, Brendan K. \| ... \| Robertson, Gregory T. Antimicrobial Agents and Chemotherapy, volume 67, issue 11 (2023). 10.1128/aac.00597-23 Cited by (2) \| Cite \| Source
Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycins (journal article) Ganapathy, Uday S. \| Lan, Tian \| Dartois, Véronique \| Aldrich, Courtney C. \| Dick, Thomas Microbiology Spectrum, volume 11, issue 5 (2023). 10.1128/spectrum.01900-23 Cited by (2) \| Cite \| Source
Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses (journal article) Walter, Nicholas D. \| Ernest, Jackie P. \| Dide-Agossou, Christian \| Bauman, Allison A. \| Ramey, Michelle E. \| Rossmassler, Karen \| Massoudi, Lisa M. \| Pauly, Samantha \| Al Mubarak, Reem \| Voskuil, Martin I. \| ... \| Robertson, Gregory T. Antimicrobial Agents and Chemotherapy, volume 67, issue 9 (2023). 10.1128/aac.00284-23 Cited by (3) \| Cite \| Source
ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant M. abscessus in caseum surrogate (journal article) Xie, Min \| Ganapathy, Uday S. \| Lan, Tian \| Osiecki, Paulina \| Sarathy, Jansy P. \| Dartois, Véronique \| Aldrich, Courtney C. \| Dick, Thomas Antimicrobial Agents and Chemotherapy, volume 67, issue 9 (2023). 10.1128/aac.00381-23 Cited by (1) \| Cite \| Source
Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus (journal article) Negatu, Dereje A. \| Aragaw, Wassihun Wedajo \| Dartois, Véronique \| Dick, Thomas Microbiology Spectrum, volume 11, issue 4 (2023). 10.1128/spectrum.02199-23 Cited by (1) \| Cite \| Source
Wild mouse gut microbiota limits initial tuberculosis infection in BALB/c mice (journal article) Xie, Min \| Tsai, Chen-Yu \| McAdams, Zachary L. \| Oo, Myo \| Hansen, Mark \| Dougher, Maureen \| Sansano, Alexander \| Watson, Anderson \| LoMauro, Katherine \| Antilus-Sainte, Rosleine \| ... \| Gengenbacher, Martin PLOS ONE, volume 18, issue 7, pages e0288290- (2023). 10.1371/journal.pone.0288290 Cite \| Source
Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens (journal article) Budak, Maral \| Cicchese, Joseph M. \| Maiello, Pauline \| Borish, H. Jacob \| White, Alexander G. \| Chishti, Harris B. \| Tomko, Jaime \| Frye, L. James \| Fillmore, Daniel \| Kracinovsky, Kara \| ... \| Kirschner, Denise E. PLOS Computational Biology, volume 19, issue 6, pages e1010823- (2023). 10.1371/journal.pcbi.1010823 Cited by (4) \| Cite \| Source
Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in Mycobacteria (journal article) Malwal, Satish R. \| Mazurek, Ben \| Ko, Jihee \| Xie, Pujun \| Barnes, Chikako \| Varvitsiotis, Christine \| Zimmerman, Matthew D. \| Olatunji, Samir \| Lee, Jaeyong \| Xie, Min \| ... \| Oldfield, Eric Journal of Medicinal Chemistry, volume 66, issue 11, pages 7553-7569 (2023). 10.1021/acs.jmedchem.3c00398 Cite \| Source
The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability (journal article) Namasivayam, Sivaranjani \| Zimmerman, Matthew \| Oland, Sandra \| Wang, Han \| Mittereder, Lara R. \| Dartois, Véronique \| Sher, Alan mBio, volume 14, issue 2 (2023). 10.1128/mbio.00353-23 Cited by (1) \| Cite \| Source
Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections (journal article) Negatu, Dereje A. \| Aragaw, Wassihun Wedajo \| Cangialosi, Julianna \| Dartois, Véronique \| Dick, Thomas Antimicrobial Agents and Chemotherapy, volume 67, issue 4 (2023). 10.1128/aac.01655-22 Cited by (7) \| Cite \| Source
Adaptation to the intracellular environment of primary human macrophages influences drug susceptibility of Mycobacterium tuberculosis (journal article) Lanni, Faye \| Wijnant, Gert-Jan \| Xie, Min \| Osiecki, Paulina \| Dartois, Véronique \| Sarathy, Jansy P. Tuberculosis, volume 139 (2023). 10.1016/j.tube.2023.102318 Cited by (1) \| Cite \| Source
Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection (journal article) Negatu, Dereje A. \| González del Río, Rubén \| Cacho-Izquierdo, Mónica \| Barros-Aguirre, David \| Lelievre, Joël \| Rullas, Joaquín \| Casado, Patricia \| Ganapathy, Uday S. \| Zimmerman, Matthew D. \| Gengenbacher, Martin \| ... \| Dick, Thomas Antimicrobial Agents and Chemotherapy, volume 67, issue 2 (2023). 10.1128/aac.01459-22 Cited by (8) \| Cite \| Source

Title	Investigators	Year	Cost	Agency
Pharmacology	Dartois, Veronique \| Glickman, Michael Stephen	2020	$485,275	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Translational approaches to improve understanding and outcome in Tuberculous meningitis	Dartois, Veronique \| Wilkinson, Robert John	2020	$750,865	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence	Alland, David \| Dartois, Veronique \| Salgame, Padmini	2020	$712,219	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Target based discovery of next generation pyrazinamide	Dartois, Veronique \| Dick, Thomas	2020	$797,081	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Lesion-centric optimization of multidrug therapies for tuberculosis	Aldridge, Bree Beardsley \| Dartois, Veronique \| Kirschner, Denise E	2020	$869,259	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Core C Pharmacology	Dartois, Veronique	2020	$616,666	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Targeting Biotin Metabolism in Mycobacterium Tuberculosis	Aldrich, Courtney C \| Dartois, Veronique \| Schnappinger, Dirk	2020	$779,863	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Target based discovery of next generation pyrazinamide	Dartois, Veronique \| Dick, Thomas	2019	$838,267	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
A Multi-scale systems pharmacology approach to TB therapy	Dartois, Veronique \| Flynn, Joanne L. \| Kirschner, Denise E \| Linderman, Jennifer Jean	2019	$717,296	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence	Alland, David \| Dartois, Veronique \| Salgame, Padmini	2019	$777,574	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Pharmacology	Dartois, Veronique \| Glickman, Michael Stephen	2019	$501,029	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Targeting Biotin Metabolism in Mycobacterium Tuberculosis	Aldrich, Courtney C \| Dartois, Veronique \| Schnappinger, Dirk	2019	$820,039	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Core C Pharmacology	Dartois, Veronique	2019	$594,171	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
A Multi-scale systems pharmacology approach to TB therapy	Dartois, Veronique \| Flynn, Joanne L. \| Kirschner, Denise E \| Linderman, Jennifer Jean	2018	$717,122	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence	Alland, David \| Dartois, Veronique \| Salgame, Padmini	2018	$264,427	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Target based discovery of next generation pyrazinamide	Dartois, Veronique \| Dick, Thomas	2018	$769,649	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
In Vitro and In Vivo Pharmacokinetics Core	Dartois, Veronique	2018	$253,775	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence	Alland, David \| Dartois, Veronique \| Salgame, Padmini	2018	$385,878	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Pharmacology	Dartois, Veronique \| Glickman, Michael Stephen	2018	$485,623	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
In Vitro and In Vivo Pharmacokinetics Core	Dartois, Veronique	2018	$330,828	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
De facto monotherapy during multidrug TB treatment and emergence of resistance	Alland, David \| Dartois, Veronique	2018	$786,135	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
In Vitro and In Vivo Pharmacokinetics Core	Dartois, Veronique	2017	$520,992	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
De facto monotherapy during multidrug TB treatment and emergence of resistance	Alland, David \| Dartois, Veronique	2017	$788,371	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
A QTRAP 6500 LC-MS/MS System from SCIEX for high accuracy drug content analysis	Dartois, Veronique	2017	$526,083	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH
Pharmacology	Dartois, Veronique \| Glickman, Michael Stephen	2017	$491,841	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence	Alland, David \| Dartois, Veronique \| Salgame, Padmini	2017	$587,529	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
A Multi-scale systems pharmacology approach to TB therapy	Dartois, Veronique \| Flynn, Joanne L. \| Kirschner, Denise E \| Linderman, Jennifer Jean	2017	$714,113	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection	Dartois, Veronique	2016	$788,180	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
A Multi-scale systems pharmacology approach to TB therapy	Kirschner, DENISE E (contact) \| Linderman, Jennifer Jean \| Flynn, Joanne L. \| Dartois, Veronique	2016	$800,540	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
In Vitro and In Vivo Pharmacokinetics Core	Dartois, Veronique	2016	$487,591	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection	Dartois, Veronique	2015	$788,890	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
In Vitro and In Vivo Pharmacokinetics Core	Dartois, Veronique	2015	$465,845	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
A MALDI LTQ Orbitrap XL Mass Spectrometer for BioImaging	Dartois, Veronique	2015	$417,944	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection	Dartois, Veronique	2014	$789,586	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
In Vitro and In Vivo Pharmacokinetics Core	Dartois, Veronique	2014	$460,655	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection	Dartois, Veronique	2013	$771,638	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES